Sonoma Pharmaceuticals Inc. (SNOA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sonoma Pharmaceuticals In...

    NASDAQ: SNOA · Real-Time Price · USD
    4.04
    -0.02 (-0.49%)
    At close: Sep 26, 2025, 3:58 PM
    4.02
    -0.50%
    After-hours: Sep 26, 2025, 07:44 PM EDT

    Sonoma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 14.29M 12.73M 13.27M 12.63M 18.63M
    Cost of Revenue
    		 8.82M 7.99M 8.79M 8.63M 12.07M
    Gross Profit
    		 5.46M 4.75M 4.48M 3.99M 6.56M
    Operating Income
    		 -3.71M -4.7M -4.57M -5.89M -3.45M
    Interest Income
    		 n/a n/a 16K 10K 16K
    Pretax Income
    		 -2.91M -5.03M -5.18M -5.42M -3.9M
    Net Income
    		 -3.46M -4.83M -5.15M -5.09M -3.95M
    Selling & General & Admin
    		 7.36M 7.58M 8.84M 9.76M 9.45M
    Research & Development
    		 1.81M 1.87M 207K 125K 555K
    Other Expenses
    		 n/a n/a n/a n/a n/a
    Operating Expenses
    		 9.18M 9.45M 9.05M 9.88M 10.01M
    Interest Expense
    		 n/a n/a 16K 10K 12K
    Selling & Marketing Expenses
    		 n/a 156K 156K 86K 41K
    Cost & Expenses
    		 18M 17.44M 17.84M 18.52M 22.08M
    Income Tax Expense
    		 550K -196K -33K -332K 713K
    Shares Outstanding (Basic)
    		 1.24M 909K 339.4K 265.3K 199.6K
    Shares Outstanding (Diluted)
    		 1.24M 909K 339.4K 265.3K 199.6K
    EPS (Basic)
    		 -2.79 -5.32 -15.18 -19.17 -23.65
    EPS (Diluted)
    		 -2.79 -5.32 -15.18 -19.17 -23.65
    EBITDA
    		 -3.57M -4.53M -4.45M -5.7M -3.22M
    EBIT
    		 -3.71M -4.7M -4.57M -5.89M -3.45M
    Depreciation & Amortization
    		 138K 176K 125K 186K 227K

    Add to Watchlist